Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-25T09:51:04.975Z Has data issue: false hasContentIssue false

National Survey of Infectious Diseases Physicians on Prevention Practices for Multidrug-Resistant Acinetobacter baumannii in Thailand

Published online by Cambridge University Press:  11 January 2016

Anucha Apisarnthanarak*
Affiliation:
Division of Infectious Diseases, Faculty of Medicine, Thammasat University, Pathumthani, Thailand
Aubonphan Buppajarntham
Affiliation:
Division of Infectious Diseases, Faculty of Medicine, Thammasat University, Pathumthani, Thailand
Linda M. Mundy
Affiliation:
Luitpold Pharmaceuticals, Inc., Norristown, Pennsylvania, United States.
*
Address correspondence to Anucha Apisarnthanarak, MD, Division of Infectious Diseases, Faculty of Medicine, Thammasat University, Pathumthani, Thailand, 10120 ([email protected]).
Rights & Permissions [Opens in a new window]

Abstract

Type
Letters to the Editor
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

To the Editor—Multidrug-resistant Acinetobacter baumannii (MDRAB) has emerged as a major cause of healthcare-associated infection and has become an infection prevention and control (IPC) challenge.Reference Dejsirilert, Tiengrim, Sawanpanyalert, Aswapokee and Malathum 1 Reference Apisarnthanarak, Khawcharoenporn and Mundy 3 The results of a prior Thai national survey indicated that a physician leader in infection control and participation in a collaborative effort to prevent MDR organisms were associated with a reduction in drug-resistant A. baumannii infections.Reference Apisarnthanarak, Khawcharoenporn and Mundy 3 A paucity of data regarding effective infection prevention of MDRAB prompted a 2014–2015 national survey to evaluate practices aimed at minimizing endemicity and reducing the spread of MDRAB.

Between June 1, 2014, and March 1, 2015, board-certified infectious diseases physicians (IDPs) in Thailand were interviewed using a standardized questionnaire. Survey items included IPC hospital activities, policies, and outcomes associated with MDRAB control. All IDPs were invited to participate in this study, and 1 IDP per hospital with responsibility for MDRAB control was interviewed if consent was obtained. The study exclusion criterion was decline for interview. Data variables included hospital characteristics, IPC practices and MDRAB policies, and estimated rates of MDRAB infection. Hospital characteristics included type and level of hospital, medical school affiliation, and participation in a collaborative network to reduce multidrug-resistant organisms (MDROs), safety score, leadership support, and prevalence of MDROs. The rates of MDRAB before and after implementation of IPC policies were acquired from IPC databases, and implementation of IPC was defined as implementation of standard versus intensified IPC interventions to control MDRAB based on the recommendations of the Healthcare Infection Control Practices Advisory Committee.Reference Siegel, Rhinehart, Jackson and Chiarello 4 All data pertaining to IPC and compliance with each recommended measure were abstracted from each hospital’s infection control (IC) database.

Standard IC interventions were defined as existing hospital interventions for hand hygiene, contact isolation, cohort isolation, and environmental cleansing. Intensified IC intervention were defined as existing hospital interventions for active surveillance cultures, intensified environmental cleansing (eg, use of hydrogen peroxide vaporization), and source control strategies (eg, chlorhexidine bath).Reference Siegel, Rhinehart, Jackson and Chiarello 4 Hospital compliance with IC interventions was categorized as low (<40%), moderate (40%–75%), or high (>75%).Reference Buppajarntham, Apisarnthanarak, Khawcharoenporn, Rutjanawech and Singh 5 Successful MDRAB reduction was defined as >25% reduction in the hospital’s MDRAB infection rate 12 months after the implementation of an IC protocol to control MDRAB. Each institution’s safety culture was assessed using a validated safety score metric, calculated as the mean of responses in agreement with 2 standard statements about safety.Reference Apisarnthanarak, Greene, Kennedy, Khawcharoenporn, Krein and Saint 6 Before calculating the survey scores, relevant responses were reverse coded; a higher score indicated greater emphasis on patient safety.Reference Buppajarntham, Apisarnthanarak, Khawcharoenporn, Rutjanawech and Singh 5 Infection control support was defined, as previously described, by a composite response to staffing, financial, and political aspects by hospital administration, which were categorized by the lead IDP as poor, fair, good, very good, or excellent.Reference Apisarnthanarak, Greene, Kennedy, Khawcharoenporn, Krein and Saint 6 Good and excellent support were combined as a single response in the multivariate analysis.

Among 183 board-certified IDPs across 43 hospitals in Thailand, 43 IDPs were involved in IPC activities and met study inclusion criteria. Of these 43 IDPs, 36 (84%) worked at tertiary care hospitals, and 39 (90%) served as chairs of their respective IC committee. The most commonly reported MDR pathogens were MDRAB (30 of 43 hospitals; 70%) and carbapenem-resistant A. baumannii (13 of 43 hospitals; 30%). Standard IC interventions were implemented in 15 hospitals (35%), while intensified IC interventions were implemented in 28 hospitals (65%). Overall, 22 hospitals (54%) reported successful MDRAB reduction (Table 1). Most hospitals reported moderate-to-high compliance with hand hygiene (100%), contact isolation (93%), and environmental cleaning (91%). Intensified interventions were used less often: chlorhexidine bath (27%), hydrogen peroxide vaporizer (17%), and active surveillance (17%). By multivariate analysis, IDPs from hospitals with successful containment reported good-to-excellent leadership support (adjusted odds ratio [aOR], 10.19; 95% confidence interval [CI], 1.24–24.42; P=.001), working at a private hospital (aOR, 5.4; 95% CI, 1.5–45.42; P=.04), implementation of intensified IPC interventions in addition to standard IC practices (aOR, 9.3; 95% CI, 2.24–36.69; P=.004), and involvement in collaborative networks (aOR, 6.4; 95% CI, 2.12–54.45; P=.02).

TABLE 1 Characteristics of 43 Hospitals with Infectious Diseases (ID) Physicians who Reported Multidrug-Resistant Acinetobacter baumannii (MDRAB) Infection Prevention and Control Strategies

NOTE. Unless indicated otherwise, analyses were performed using SPSS, Statistics version (IBM, Armonk, NY). Fisher’s exact or χ2 test was used to compare categorical data, as appropriate. Continuous variables were compared using the Mann-Whitney U Test. All P values were 2-tailed; P<.05 was considered statistically significant; multivariate analysis was performed to evaluate factors associated with successful implementation of IPC intervention to reduce MDR-Acinetobacter baumannii.

In a previous Thai national survey to evaluate endemic MDRAB risks, a physician-led IC team and participation in a collaborative effort to prevent MDRAB were associated with implementation of MDRAB IPC policies.Reference Apisarnthanarak, Khawcharoenporn and Mundy 3 Notably, no analysis was performed to evaluate the predictors for containment of MDRAB in that study.Reference Apisarnthanarak, Khawcharoenporn and Mundy 3 Likewise, hospitals with good-to-excellent safety culture, administrative support, and participation in a collaborative effort were predictors of policies to reduce healthcare-associated infections in 2 Asia-Pacific countries.Reference Apisarnthanarak, Greene, Kennedy, Khawcharoenporn, Krein and Saint 6 , Reference Sakamoto, Sakihama, Saint, Greene, Ratz and Tokuda 7 These are essential prerequisites that hospitals should have in place to achieve successful MDRO IPC. In this study, we confirm that both hospital-level factors (ie, excellent safety culture and leadership support) and individual-level factors (ie, knowledge regarding implementation of intensified IC programs and involvement in collaborative networks) are important predictors for successful containment of MDRAB in hospitals with IDPs in Thailand.

We are aware of several limitations in this study. First, the small sample size limited our capacity to analyze other important factors potentially associated with successful containment of MDROs (eg, predictors for implementation of individual intervention and level of compliance needed to achieve successful containment of each intervention). Second, survey data were subject to recall bias associated with interventions that each IDP implemented. This bias was likely low given that all information was derived from hospital IC databases, including levels of compliance with each IPC intervention. Nonetheless, our study highlights some important modifiable gaps in MDRO containment. Further education regarding implementation of intensified IC interventions, along with sustainable IDP networks, is needed to contain the increase in MDRAB prevalence in this middle-income country.

ACKNOWLEDGMENTS

Financial support. No financial support was provided relevant to this article.

Potential conflicts of interest. A.A. was supported by the National Research University Project of the Thailand Office of Higher Education Commission. L.M.M. conducted this work pro bono and independent of her employment at Luitpold Pharmaceuticals, Inc. (LPI).

References

REFERENCES

1. Dejsirilert, S, Tiengrim, S, Sawanpanyalert, P, Aswapokee, N, Malathum, K. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance. J Med Assoc Thai 2009;91(Suppl4):S34S45.Google Scholar
2. Apisarnthanarak, A, Buppunharun, W, Tiengrim, S, Sawanpanyalert, P, Aswapokee, N. An overview of antimicrobial susceptibility patterns for gram-negative bacteria from the National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005. J Med Assoc Thai 2009;92(Suppl4):S91S94.Google Scholar
3. Apisarnthanarak, A, Khawcharoenporn, T, Mundy, LM. Practices to prevent multidrug-resistant Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus in Thailand: a national survey. Am J Infect Control 2013;41:416421.Google Scholar
4. Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L, Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. Am J Infect Control 2007;35(10Suppl2):S165S193.Google Scholar
5. Buppajarntham, A, Apisarnthanarak, A, Khawcharoenporn, T, Rutjanawech, S, Singh, N. National survey of Thai Infectious Diseases physicians on treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia: the role of infection control awareness? Infect Control Hosp Epidemiol 2016;37:6169.Google Scholar
6. Apisarnthanarak, A, Greene, MT, Kennedy, EH, Khawcharoenporn, T, Krein, S, Saint, S. National survey of practices to prevent healthcare-associated infections in Thailand: the role of safety culture and collaboratives. Infect Control Hosp Epidemiol 2013;33:711717.CrossRefGoogle Scholar
7. Sakamoto, F, Sakihama, T, Saint, S, Greene, MT, Ratz, D, Tokuda, Y. Health care-associated infection prevention in Japan: the role of safety culture. Am J Infect Control 2014;42:888893.Google Scholar
Figure 0

TABLE 1 Characteristics of 43 Hospitals with Infectious Diseases (ID) Physicians who Reported Multidrug-Resistant Acinetobacter baumannii (MDRAB) Infection Prevention and Control Strategies